Evidence map›Paper›PMID 37850579›Full record

ReviewAJR. American journal of roentgenology2024

Update on DWI for Breast Cancer Diagnosis and Treatment Monitoring.

Roberto Lo Gullo, Savannah C Partridge, Hee Jung Shin, Sunitha B Thakur, Katja Pinker

Open access · bronzeAbstract readReview
In one paragraph

Review in AJR. American journal of roentgenology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 1 pooled it
9.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 1 synthesis or guideline pooled it, 40 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Monitoring Pharmacological Treatment of Breast Cancer with MRI.Current issues in molecular biology · 2025
    Review
  16. Article
  17. Review
  18. Article
  19. Breast Diffusion-weighted MR Imaging: Current Applications, Insights from Screening, and Future Directions.Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine · 2025
    Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Roberto Lo GulloDepartment of Radiology, Memorial Sloan Kettering Cancer Center, 300 E 66th St, New York, NY 10065.
Savannah C PartridgeDepartment of Radiology, University of Washington School of Medicine, University of Washington, Seattle, WA.
Hee Jung ShinDepartment of Radiology and Research Institute of Radiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
Sunitha B ThakurDepartment of Radiology, Memorial Sloan Kettering Cancer Center, 300 E 66th St, New York, NY 10065.
Katja PinkerDepartment of Radiology, Memorial Sloan Kettering Cancer Center, 300 E 66th St, New York, NY 10065.
Asan Medical Center · KRMemorial Sloan Kettering Cancer Center · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
Translational Bioimaging Core Shared ResourceP30CA015704 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI Eric Collisson · 1985 to 2026
$296.4M
Multicenter Quantitative MRI Assessment of Breast Cancer Therapy ResponseR01CA248192 · NCI · WILLIAM BEAUMONT HOSPITAL RESEARCH INST · PI WEI HUANG, James H Holmes · 2021 to 2026
$2.8M
Validation and Standardization of the Apparent Diffusion Coefficient as a Quantitative Imaging Biomarker in Breast CancerR01CA207290 · NCI · UNIVERSITY OF WASHINGTON · PI PARTRIDGE, SAVANNAH CORRINA · 2017 to 2022
$2.2M
NCI NIH HHS P30 CA008748NCI NIH HHS P30 CA015704NCI NIH HHS R01 CA207290
6 · The paper itself

Abstract

DWI is a noncontrast MRI technique that measures the diffusion of water molecules within biologic tissue. DWI is increasingly incorporated into routine breast MRI examinations. Currently, the main applications of DWI are breast cancer detection and characterization, prognostication, and prediction of treatment response to neoadjuvant chemotherapy. In addition, DWI is promising as a noncontrast MRI alternative for breast cancer screening. Problems with suboptimal resolution and image quality have restricted the mainstream use of DWI for breast imaging, but these shortcomings are being addressed through several technologic advancements. In this review, we present an up-to-date assessment of the use of DWI for breast cancer imaging, including a summary of the clinical literature and recommendations for future use.

Indexed as

Breast NeoplasmsBreastDiffusion Magnetic Resonance ImagingFemaleHumansImage EnhancementSensitivity and Specificitybreast cancerdiagnosisDWItreatment monitoring

Identifiers

PMID37850579
PMCPMC11196747
OpenAlexW4387729594

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.